title: Correlation between intracellular cAMP content, kinematic parameters and hyperactivation of human spermatozoa after incubation with pentoxifylline.
abstract: Various compounds have been used in the attempt to improve sperm motility, including pentoxifylline (PF), a methylxanthine derivative. It has been postulated that PF, being a phosphodiesterase inhibitor, increases sperm kinematic parameters and the number of spermatozoa exhibiting hyperactivated motility by raising the intracellular content of cAMP, a molecule involved in the generation of sperm energy. However, it has not been clarified whether the biological effects of PF on sperm motility correlate with its ability to increase intracellular cAMP levels. To examine this relationship, the kinematic parameters, hyperactivation, and intracellular cAMP content were evaluated in motile spermatozoa, obtained by discontinuous Percoll gradient and swim-up from 21 normozoospermic semen samples, incubated without and with PF for 0, 1, 2, and 4 h. PF increased beat cross frequency after 1 and 2 h of incubation, curvilinear velocity and lateral head displacement (ALH) after 4 h, and hyperactivation after 1, 2, and 4 h, and decreased linearity (LIN) after 1 h of incubation. The intracellular cAMP content of spermatozoa incubated with PF increased at all time-points examined. Both intracellular cAMP content and increase in hyperactivation in response to PF decreased with the length of incubation. In the absence of PF, cAMP content was unchanged and was correlated significantly only with ALH and the percentage of spermatozoa with hyperactivated motility. Following incubation with PF, cAMP content correlated with hyperactivation and all sperm kinematic parameters, with the exception of LIN and straightness. These findings suggest that the beneficial effects of PF on sperm kinematic parameters and hyperactivation are related to its ability to increase intracellular cAMP content.
authors.affiliation: Department of Internal Medicine, University of Catania Medical School, Italy.
authors.forename: A E
authors.initials: AE
authors.lastname: Calogero
authors.forename: S
authors.initials: S
authors.lastname: Fishel
authors.forename: J
authors.initials: J
authors.lastname: Hall
authors.forename: E
authors.initials: E
authors.lastname: Ferrara
authors.forename: E
authors.initials: E
authors.lastname: Vicari
authors.forename: S
authors.initials: S
authors.lastname: Green
authors.forename: A
authors.initials: A
authors.lastname: Hunter
authors.forename: N
authors.initials: N
authors.lastname: Burrello
authors.forename: S
authors.initials: S
authors.lastname: Thornton
authors.forename: R
authors.initials: R
authors.lastname: D'Agata
mesh_terms: D000242:Cyclic AMP / Q000378:metabolism*; D006801:Humans; D007425:Intracellular Membranes / Q000378:metabolism*; D008297:Male; D010431:Pentoxifylline / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D013081:Sperm Motility / Q000187:drug effects* / Q000502:physiology*; D013094:Spermatozoa / Q000187:drug effects* / Q000378:metabolism*
chemical_list: D010726:Phosphodiesterase Inhibitors; D000242:Cyclic AMP; D010431:Pentoxifylline